Browsing the "Sofinnova Ventures" Tag →

27 2014 May
By FinSMEs
0 Comments

Spark Therapeutics Completes $72.8M Series B Financing

Spark Therapeutics, a Philadelphia, PA-based late-stage company developing gene-based medicines for a wide range of rare, debilitating diseases, completed a...

Read More →
19 2014 May
By FinSMEs
0 Comments

Coherus BioSciences Closes $55M Series C Financing

Coherus BioSciences, Inc., a San Francisco, CA-based biologics platform company focused on biosimilars, closed a $55m Series C financing. New...

Read More →
15 2014 May
By FinSMEs
0 Comments

Sorbent Therapeutics Closes $6.5M Tranche in $15M Series D Financing

Sorbent Therapeutics, Inc., a Sunnyvale, California-based biopharmaceutical company developing therapies for cardiovascular and renal diseases, closed a $6.5m tranche in...

Read More →
22 2014 April
By FinSMEs
0 Comments

Principia Biopharma Raises $50M in Series B Financing

Principia Biopharma Inc., a South San Francisco, CA-based biopharmaceutical company, raised $50m in Series B financing. The round was led...

Read More →
11 2014 April
By FinSMEs
0 Comments

NuCana Completes $57M Series B Financing

NuCana, an Edinburgh, UK-based clinical stage biopharmaceutical company, completed a $57m Series B financing. The round was led by new...

Read More →
06 2014 March
By FinSMEs
0 Comments

ZS Pharma Completes $55M Series D Financing

ZS Pharma, a Coppell, TX-based specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, completed a $55m...

Read More →
11 2014 February
By FinSMEs
0 Comments

First Aid Shot Therapy Completes Series B Financing Round

First Aid Shot Therapy (F.A.S.T.), a Burlingame, California-based consumer healthcare company, completed its Series B financing round. The round –...

Read More →
08 2013 October
By FinSMEs
1 Comments

Versartis Completes $20M Series D Financing

Versartis, Inc., a Redwood City, CA-based biotechnology company developing novel therapeutics for patients with endocrine disorders, completed a $20m Series D financing....

Read More →
29 2013 August
By FinSMEs
0 Comments

ObsEva Closes CHF32M Series A Financing

ObsEva, a Geneva, Switzerland-based biopharmaceutical company dedicated to the development of innovative drugs for women’s reproductive medicine, closed a CHF32m...

Read More →
10 2013 July
By FinSMEs
0 Comments

Crocus Technology Raises €34M in Series D Funding

Crocus Technology, a Grenoble, France-based developer of magnetically enhanced semiconductor technologies for mobile security, embedded microcontrollers, harsh environment electronics and...

Read More →
22 2013 May
By FinSMEs
1 Comments

First Aid Shot Therapy Completes Series A Financing

First Aid Shot Therapy, Inc., a Burlingame, California-based consumer healthcare company focused on over-the-counter (OTC) therapies in liquid ‘shot’ (40ml...

Read More →
17 2013 April
By FinSMEs
0 Comments

Auris Medical Completes CHF47.1M Series C Financing

Auris Medical, a Basel, Switzerland-based biotechnology company that develops novel therapeutics for the treatment of inner ear disorders, completed a...

Read More →
10 2013 January
By FinSMEs
3 Comments

Guavus Closes $30M Funding

Guavus Inc., a San Mateo, CA-based provider of big data analytics solutions, closed a $30m funding. The round was led...

Read More →
07 2013 January
By FinSMEs
0 Comments

Marinus Pharmaceuticals Raises $21M Funding in Series C Financing

Marinus Pharmaceuticals, Inc., a Branford, Conn.-based developer of a neuroactive steroid, raised an additional $21m funding in Series C financing....

Read More →